Valuation Gan & Lee Pharmaceuticals.

Equities

End-of-day quote Shanghai S.E. Other stock markets 22/04/2026			5-day change	1st Jan Change
65.68 ^CNY	+2.31%		+2.16%	-3.51%

04-22	Gan & Lee Pharmaceuticals 2025 net profit up 86.1% y/y	RE
04-16	Gan & Lee Pharmaceuticals Gets Nod to Trial GLR1062 Injection	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	74,247	39,499	18,429	31,066	26,332	39,093	39,093	-
Change	-	-46.8%	-53.34%	68.57%	-15.24%	48.46%	0%	-
Enterprise Value (EV) ¹	74,247	39,499	18,429	28,627	25,439	37,737	37,078	35,925
Change	-	-46.8%	-53.34%	55.34%	-11.14%	48.34%	-1.75%	-3.11%
P/E ratio	57.2x	27.2x	-41.8x	87.8x	42.4x	35.3x	27.3x	22.2x
PBR	8.31x	3.88x	-	2.91x	2.4x	-	-	-
PEG	-	2.2x	0x	-0x	0.6x	0.4x	0.9x	1x
Capitalization / Revenue	22.1x	10.9x	-	11.9x	8.65x	10x	7.46x	6.46x
EV / Revenue	22.1x	10.9x	-	11x	8.35x	9.09x	7.07x	5.94x
EV / EBITDA	-	-	-	53.2x	32x	27.2x	20.8x	16.4x
EV / EBIT	51.1x	23.2x	-	90.8x	40.3x	33.5x	25x	20.3x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	0.2	1	0.18	0.24	0.31
Rate of return	-	-	-	0.38%	2.27%	0.27%	0.37%	0.47%
EPS ²	2.31	2.59	-0.78	0.6	1.04	1.93	2.41	2.96
Distribution rate	-	-	-	33.3%	96.2%	9.63%	9.96%	10.5%
Net sales ¹	3,362	3,612	-	2,608	3,045	4,052	5,243	6,052
EBITDA ¹	-	-	-	537.8	795.7	1,387	1,783	2,190
EBIT ¹	1,453	1,699	-	315.3	631.5	1,126	1,483	1,769
Net income ¹	1,231	1,453	-439.5	340.1	614.7	1,144	1,450	1,780
Net Debt ¹	-	-	-	-2,439	-892.7	-1,356	-2,015	-3,168
Reference price ²	132.22	70.34	32.58	52.65	44.10	65.68	65.68	65.68
Nbr of stocks (in thousands)	561,540	561,540	565,653	590,049	597,089	595,202	595,202	-
Announcement Date	14/04/21	27/04/22	30/03/23	24/04/24	24/04/25	22/04/26	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GAN & LEE PHARMACEUTICALS.	34.33x	8.88x	26.58x	0.28%	5.6B
REGENERON PHARMACEUTICALS, INC.	19.19x	4.36x	13.12x	0.52%	76.69B
UCB	26.98x	5.38x	15.52x	0.59%	55.29B
SAMSUNG BIOLOGICS CO.,LTD.	38.67x	13.03x	23.84x	-.--%	49.73B
CSL LIMITED	35.64x	3.55x	10.27x	2.99%	47.08B
BIOGEN INC.	15.62x	2.94x	8.82x	-.--%	27.29B
MODERNA, INC.	-7.49x	8.45x	-6.22x	-.--%	21.51B
INCYTE CORPORATION	15.5x	2.51x	7.89x	-.--%	19.15B
SWEDISH ORPHAN BIOVITRUM AB	24.4x	4.94x	13.47x	-.--%	15.53B
BRIDGEBIO PHARMA, INC.	-39.08x	17.63x	-49.18x	-.--%	14.77B
Average	16.38x	7.17x	6.41x	0.44%	33.26B
Weighted average by Cap.	21.41x	6.45x	10.29x	0.65%